Skip to Content

Flonase Sensimist Approval History

FDA Approved: Yes (First approved August 2, 2016)
Brand name: Flonase Sensimist
Generic name: fluticasone furoate
Dosage form: Nasal Spray
Company: GlaxoSmithKline Consumer Healthcare LP
Treatment for: Allergic Rhinitis

Flonase Sensimist (fluticasone furoate) is an over-the-counter corticosteroid nasal spray indicated for the treatment of symptoms associated with seasonal and perennial allergies in adults and children ages 2 years and older.

Flonase Sensimist is administered via the nostrils once daily for 24-hour relief of both nose- and eye-related allergy symptoms such as itchy, watery eyes, nasal congestion, runny nose, itchy nose and sneezing.

Flonase Sensimist was previously available by prescription as Veramyst.

Development History and FDA Approval Process for Flonase Sensimist

DateArticle
Aug  2, 2016Approval FDA Approves Flonase Sensimist Allergy Relief

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide